Xiangqiong Wen

机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-7103-6014

发表论文 6 篇 · 总被引 84 次 · h-index 3

代表论文

• Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes (2025 · Journal of Translational Medicine · 被引 31)
• ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression (2024 · Science Advances · 被引 25)
• NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer (2024 · Science Translational Medicine · 被引 24)
• Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies (2026 · MedComm – Oncology · 被引 2)
• 88P DNA-methylome derived epigenetic fingerprint as an immunophenotype indicator prompts durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma (2022 · Annals of Oncology)
• 1583P Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancer (2022 · Annals of Oncology)